Consensus report
International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation

https://doi.org/10.1016/j.healun.2006.03.011Get rights and content

Section snippets

1. Indications

Lung transplantation is indicated for patients with chronic, end-stage lung disease who are failing maximal medical therapy, or for whom no effective medical therapy exists. Potential candidates should be well informed and demonstrate adequate health behavior and a willingness to adhere to guidelines from health care professionals.

The primary goal of lung transplantation is to provide a survival benefit. Several studies have demonstrated that lung transplantation confers such benefit,

Disease-specific lung transplantation considerations

There are no prospective, randomized, well-powered studies in lung transplantation to support the recommendations in this report. Therefore, the guidelines for referral and transplantation proposed hereafter are, for the most part, a combination of recommendations based on small and/or retrospective and/or registry studies, and expert opinion consensus. In the bulleted list of criteria given at the end of each section, unless otherwise specified, any one of the bullets suffices to recommend

Summary

Since the writing of the 1998 guidelines for the selection of candidates for lung transplantation, there has been an increased understanding of the natural history of various lung diseases as well as new treatment strategies developed that may forestall the need for transplantation for certain disorders. This has resulted in several changes to the current strategy for selecting patients for this procedure.

The primary goal of this document is to provide up-to-date guidelines to help physicians

First page preview

First page preview
Click to open first page preview

References (87)

  • T.M. Egan et al.

    Predictors of death on the UNOS lung transplant waiting listresults of a multivariate analysis

    J Heart Lung Transplant

    (2001)
  • A. De Soyza et al.

    Pulmonary transplantation for cystic fibrosispre-transplant recipient characteristics in patients dying of peri-operative sepsis

    J Heart Lung Transplant

    (2003)
  • C. Dobbin et al.

    The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosisresults from a single large referral centre

    J Hosp Infect

    (2004)
  • A. De Soyza et al.

    Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis

    Lancet

    (2001)
  • S.M. Levine

    A survey of clinical practice of lung transplantation in North America

    Chest

    (2004)
  • J.D. McMenamin et al.

    Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centersan analysis of 1,051 recent sputum isolates

    Chest

    (2000)
  • R.R. Bartz et al.

    Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis

    J Heart Lung Transplant

    (2003)
  • T. Egan et al.

    Risk factors for death after lung transplant in the U.S

    J Heart Lung Transplant

    (2003)
  • D.B. Rosenbluth et al.

    Lung function decline in cystic fibrosis patients and timing for lung transplantation referral

    Chest

    (2004)
  • F. Venuta et al.

    Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis

    J Thorac Cardiovasc Surg

    (2000)
  • F.L. Grover et al.

    Thoracic transplantation

    Am J Transplant

    (2003)
  • H. Monaghan et al.

    Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias

    Chest

    (2004)
  • E.H. Alhamad et al.

    Pulmonary function tests in interstitial lung diseasewhat role do they have?

    Clin Chest Med

    (2001)
  • T.E. King et al.

    Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis

    Chest

    (2005)
  • R. Erbes et al.

    Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?

    Chest

    (1997)
  • K. Miki et al.

    Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis

    Respir Med

    (2003)
  • S.M. Kawut et al.

    Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

    Chest

    (2003)
  • O. Sitbon et al.

    Long-term intravenous epoprostenol infusion in primary pulmonary hypertensionprognostic factors and survival

    J Am Coll Cardiol

    (2002)
  • A.F. Shorr et al.

    Outcomes for patients with sarcoidosis awaiting lung transplantation

    Chest

    (2002)
  • S.M. Arcasoy et al.

    Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation

    Chest

    (2001)
  • J.R. Maurer et al.

    International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society

    J Heart Lung Transplant

    (1998)
  • A. Geertsma et al.

    Does lung transplantation prolong life? A comparison of survival with and without transplantation

    J Heart Lung Transplant

    (1998)
  • A.B. Maish

    Priorities for lung transplantation among patients with cystic fibrosis

    JAMA

    (2002)
  • A. Connors et al.

    Outcomes following acute exacerbation of severe chronic obstructive lung disease

    Am J Respir Crit Care Med

    (1996)
  • T. Oga et al.

    Analysis of the factors related to mortality in chronic obstructive pulmonary diseaserole of exercise capacity and health status

    Am J Respir Crit Care Med

    (2003)
  • B.R. Celli et al.

    The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

    N Engl J Med

    (2004)
  • A. Fishman et al.

    A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

    N Engl J Med

    (2003)
  • 2003 annual report of the US Organ Procurement and Transplantation Network

    (2006)
  • T.M. Egan et al.

    Long-term results of lung transplantation for cystic fibrosis

    Eur J Cardiothorac Surg

    (2002)
  • T.G. Liou et al.

    Survival effect of lung transplantation among patients with cystic fibrosis

    JAMA

    (2001)
  • R.M. Aris et al.

    The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome

    Am J Respir Crit Care Med

    (1997)
  • C. Chaparro et al.

    Infection with Burkholderia cepacia in cystic fibrosisoutcome following lung transplantation

    Am J Respir Crit Care Med

    (2001)
  • R.M. Aris et al.

    Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type

    Am J Respir Crit Care Med

    (2001)
  • Cited by (0)

    View full text